Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$34 Mln
P/E Ratio
--
P/B Ratio
0.46
Industry P/E
--
Debt to Equity
0.42
ROE
-0.66 %
ROCE
43.16 %
Div. Yield
0 %
Book Value
1.78
EPS
1.01
CFO
$-207.42 Mln
EBITDA
$-284.67 Mln
Net Profit
$-305.02 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
DarioHealth (DRIO)
| 1.77 | 14.29 | 14.07 | -46.67 | -47.72 | -36.00 | -40.51 |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
DarioHealth (DRIO)
| -54.00 | -59.81 | -67.00 | -9.24 | 117.84 | -57.73 | -51.37 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.93 | 10,562.04 | 12.43 | 12.69 | |
| 72.80 | 10,050.19 | 97.07 | 2.52 | |
| 163.74 | 8,847.72 | -- | -25.23 | |
| 299.78 | 11,550.00 | 278.74 | 3.65 |
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by... data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Read more
CEO & Director
Mr. Erez Raphael
CEO & Director
Mr. Erez Raphael
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of DarioHealth Corp (DRIO) stood at $ 119 Mln as on 31-Dec-24
The share price of DarioHealth Corp (DRIO) is $0.80 (NASDAQ) as of 25-Apr-2025 16:00 EDT. DarioHealth Corp (DRIO) has given a return of -47.72% in the last 3 years.
DarioHealth Corp (DRIO) has a market capitalisation of $ 34 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of DarioHealth Corp (DRIO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the DarioHealth Corp (DRIO) and enter the required number of quantities and click on buy to purchase the shares of DarioHealth Corp (DRIO).
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
The CEO & director of Mr. Erez Raphael. is DarioHealth Corp (DRIO), and CFO & Sr. VP is Mr. Erez Raphael.
There is no promoter pledging in DarioHealth Corp (DRIO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,078
|
|
|
1,054
|
|
|
964
|
|
|
853
|
| DarioHealth Corp. (DRIO) | Ratios |
|---|---|
|
Return on equity(%)
|
62.97
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
151.56
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of DarioHealth Corp (DRIO) was $0 Mln.
$-0.02
(
